Antineutrophil Cytoplasmic Antibodies in Chronic Idiopathic Intraocular Inflammatory Disease

References

• Forrester J V. Endogenous posterior uveiti. Br J Ophthalmol 1990; 74: 620–623
   PubMed Web of Science ®Google Scholar
• Forrester J V. Uveitis pathogenesi. Lancet 1991; 338: 1498–1501
   PubMed Web of Science ®Google Scholar
• Dick A D, Cheng Y F, Purdie A T, Liversidge J, Forrester J V. Immunocytochemical analysis of blood lymphocytes in uveiti. Eye 1992; 6: 643–647
   PubMed Web of Science ®Google Scholar
• Feron E, Calder V, Lightman S. Distribution of IL-2R and CD45 RO expression on CD4+ and CD8+T- lymphocytes in posterior uveitis using 3-colour flow cytometric analysi. Curr Eye Res 1992; 11: 167–172
   PubMed Web of Science ®Google Scholar
• Deschennes J, Char D H, Kalita S. Activated T-lymphocytes in uveiti. Br J Ophthalmol 1986; 72: 83–87
   Google Scholar
• Arocker-Mettinger E, Steurer-Georgiew L, Steure M, Huber-Spitzy V, Hoelzl E, Grabner G, Kuchar A. Circulating ICAM-1 levels in serum of uveitis patient. Curr Eye Res 1992; 11: 161–166
   PubMed Web of Science ®Google Scholar
• Edelsten C, D'Cruz D, Hughes G RV, Graham E M. Antiendothelial cell antibodies in retinal vasculiti. Curr Eye Res 1992; 11: 203–208
   PubMed Web of Science ®Google Scholar
• Klok A M, Geertzen R, Rothova A, Seerp Baarsma G, Kijlstra A. Anticardiolipin antibodies in uveiti. Curr Eye Res 1992; 11: 209–213
   PubMed Web of Science ®Google Scholar
• Nussenblatt R B, Palestine A G, Chan C C. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983; 96(3)275–282
   PubMed Web of Science ®Google Scholar
• Towler H MA, Lightman S L, Forrester J V. Low dose cyclosporin therapy of ocular inflammation: preliminary report of a long term follow up study. J Autoimmunity 1992; 5(suppl A)259–264
   PubMedGoogle Scholar
• Towler H, Cliffe A, Whiting P, Forrester J V. Low dose cyclosporin A therapy in chronic posterior uveiti. Eye 1989; 3: 282–287
   PubMedGoogle Scholar
• Towler H M, Whiting P H, Forrester J V. Combination of low dose cyclosporin A and steroid therapy in chronic intraocular inflammatio. Eye 1990; 4: 514–520
   PubMed Web of Science ®Google Scholar
• Dick A D, Towler H MA, Whiting P, Forrester J V. The use of lithium clearance studies in the early detection of cyclosporin nephrotoxicity: a protocol of renal function assessment with cyclosporin therap. Curr Eye Res. 1992; 11: 215–218
   PubMed Web of Science ®Google Scholar
• Lightman S. Uveitis managemen. Lancet 1991; 338: 1501–1504
   PubMed Web of Science ®Google Scholar
• Harrison D J, Simpson R, Kharbanda R, Abernethy V E, Nimmo G. Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other condition. Thorax 1989; 44: 373–377
   PubMed Web of Science ®Google Scholar
• DeKeizer R JW, van der Woude F J. c-ANCA test and the detection of Wegener's disease in sclerokeratitis and uveitis. Curr Eye Res 1990; 9(suppl)59–61
   PubMedGoogle Scholar
• Van der Woude F J, Lobatto S, Permin H, van der Giessen M, Rasmussen N, Wiik A, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosi. Lancet 1985; 1: 425–429
   PubMed Web of Science ®Google Scholar
• Soukiasian S H, Foster S C, Niles J L, Raizman M B. Diagnostic value of ANCA in scleritis associated with Wegener's granulomatosi. Ophthalmology 1992; 99: 125–132
   PubMedGoogle Scholar
• Cohen Tervaert J W, Huitema M G, Hene R J, Sluiter W J, The T H, van der Hem G K, Kallenberg C GM. Prevention of relapses in Wegener's granulomatosis by treatment based on ANCA titr. Lancet 1990; 336: 709–711
   PubMed Web of Science ®Google Scholar
• Specks U, DeRemee R A. Significance of antibodies to cytoplasmic components of neutrophil. Thorax 1989; 44: 369–370
   PubMedGoogle Scholar
• Pulido J S, Goeken J A, Nerad J A, Sobol W M, Folberg R. Ocular manifestation of patients with circulating ANC. Arch Ophthalmol 1990; 108: 845–850
   PubMedGoogle Scholar
• Jennette C J. Antineutrophil cytoplasmic antibodies-associated diseases. A pathologist's perspectiv. Am J Kidney Dis 1991; 18: 164–170
   PubMed Web of Science ®Google Scholar
• Jayne D RW, Davies M J, Fox C JV, Black C M, Lockwood C M. Treatment of systemic vasculitis with pooled intravenous immunoglobuli. Lancet 1991; 337: 1137–1139
   PubMed Web of Science ®Google Scholar
• Jayne D RW, Jones S J, Severn A, Shaunak S, Murphy J, Lockwood C M. Severe pulmonary haemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasmic antibodies of IgM class onl. Clin Nephrol 1989; 32: 101–106
   PubMed Web of Science ®Google Scholar
• Young D W, Dring S, Thompson R. Anti-neutrophil cytoplasmic antibodies in uveiti. Curr Eye Res 1990; 9: 41–44
   PubMed Web of Science ®Google Scholar
• Young D W. The antineutrophil antibody in uveiti. Br J Ophthalmol 1991; 75: 208–211
   PubMedGoogle Scholar
• Ayliffe W, Haeney M, Roberts S C, Lavin M. Uveitis after ANCA contamination of immunoglobulin replacement therap. Lancet 1992; 339: 558–559
   PubMedGoogle Scholar
• Hagen E C, van de Vijver-Reenalda H, de Keizer R JW, Kijlstra A, van Es L A, Daha M R, van der Woude F J. Uveitis and ANC. Clin Exp Immunol 1994; 95: 56–59
   PubMedGoogle Scholar
• Jenne D E, Tschopp J, Ludermann J, Utecht B, Gross W L. Wegener's autoantigen decoded. Nature 1990; 346: 520
   PubMed Web of Science ®Google Scholar
• Lesavre P. Antineutrophil cytoplasmic antibodies antigen specificit. Am J Kidney Dis 1991; 18: 159–163
   PubMedGoogle Scholar
• Jennette C J, Falk R J. Antineutrophil cytoplasmic antibodies and associated diseases: A revie. Am J Kidney Dis 1990; 15: 517–529
   PubMed Web of Science ®Google Scholar
• Gross W L, Csernok E, Schmitt W H. ANCA: Immunological aspect. Klin Wschr 1991; 69: 558–566
   PubMedGoogle Scholar
• Gross W L, Schmitt W H, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspect. Clin Exp Immunol 1993; 91: 1–12
   PubMed Web of Science ®Google Scholar
• Nussenblatt R B, Palestine A G, Chan C C, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveiti. Ophthalmology 1985; 92: 467–471
   PubMed Web of Science ®Google Scholar
• Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97(suppl.6)12–14
   Google Scholar
• Hagen C E, Ballieux B EPB, van Es L A, Daha M R, van der Woude F J. ANCA: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequence. Blood 1993; 81: 1996–2002
   PubMed Web of Science ®Google Scholar
• Falk R J, Terrell R S, Charles L A, Jennette C J. ANCA induce neutrophils to degranulate and produce oxygen radical in vitr. Proc Natl Acad Sci USA 1990; 87: 4115–4119
   PubMed Web of Science ®Google Scholar
• Van der Woude F J, Daha M R, van Es L A. The current status of neutrophil cytoplasmic antibodie. Clin Exp Immunol 1989; 78: 143–148
   PubMed Web of Science ®Google Scholar
• Kallenberg C GM, Cohen Tervaert J W, van der Woude F J, Goldschmeding R, von dem Borne A EGKr, Weening J J. Autoimmunity to lysosomal enzymes: new clue to vasculitis and glomerulonephritis?. Immunol Today 1991; 12: 61–64
   PubMedGoogle Scholar
• Ewert B, Jennette C J, Falk R. ANCA stimulate cytokine-primed neutrophils to damage endothelial cells. J Am Soc Nephrol 1990; 1: 520
   Google Scholar
• Savage C OS, Pottinger B E, Gaskin G, Pusey C D, Pearson J D. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cell. Am J Pathol 1992; 141: 335–342
   PubMed Web of Science ®Google Scholar